Clinical Study | Office of Clinical Research

Phase I Study Of The Non-Receptor Kinase Inhibitor Bosutinib In Combination With Pemetrexed In Patients With Selected Metastatic Solid Tumors.

Posted Date: May 15, 2019

Investigator Initiated UCCI-EXP-16-01

To Be Eligible To Participate In This Study, Study Participants Must Have Biopsy Proven Non-Squamous

Cancer, Ucci-Exp-16-01, Solid Tumor, Phase I, Metastatic Solid Tum

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List